应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DCTH 迪卡斯
盘前交易 12-24 07:49:01 EST
11.44
+0.43
+3.91%
盘前
11.52
+0.08
+0.70%
07:47 EST
最高
11.51
最低
10.75
成交量
27.67万
今开
11.08
昨收
11.01
日振幅
6.90%
总市值
3.66亿
流通市值
2.91亿
总股本
3,197万
成交额
308.98万
换手率
1.09%
流通股本
2,541万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
德尔卡斯系统公司报告截至 9 月 30 日的季度业绩 - 收益摘要
路透中文 · 11-09
德尔卡斯系统公司报告截至 9 月 30 日的季度业绩 - 收益摘要
Delcath Systems Inc 预计每股亏损20美分 - 财报前瞻
路透中文 · 11-06
Delcath Systems Inc 预计每股亏损20美分 - 财报前瞻
更新版 2-消费者支出放缓,希尔顿下调 2024 年客房收入增长预期
路透中文 · 10-23
更新版 2-消费者支出放缓,希尔顿下调 2024 年客房收入增长预期
BUZZ-德尔卡斯系统公司第三季度营收预期高于预期,公司业绩上涨
Reuters · 10-18
BUZZ-德尔卡斯系统公司第三季度营收预期高于预期,公司业绩上涨
这9只生物科技股今年已暴涨翻倍,分析师预测未来还有翻倍空间!
老虎资讯综合 · 10-17
这9只生物科技股今年已暴涨翻倍,分析师预测未来还有翻倍空间!
德尔卡斯系统公司公布截至 6 月的季度业绩 - 收益摘要
Reuters · 08-06
德尔卡斯系统公司公布截至 6 月的季度业绩 - 收益摘要
迪卡斯系统:核准有效期为从10月1日开始的财政年度。
智通财经 · 08-05
迪卡斯系统:核准有效期为从10月1日开始的财政年度。
迪卡斯:康哲药业获得Hepzato套件的CMS Ntap状态。
智通财经 · 08-05
迪卡斯:康哲药业获得Hepzato套件的CMS Ntap状态。
Delcath Systems Inc 预计每股亏损36美分 - 财报前瞻
Reuters · 08-02
Delcath Systems Inc 预计每股亏损36美分 - 财报前瞻
美国研究综述-Alphabet、Equity Residential、Infinera
Reuters · 06-28
美国研究综述-Alphabet、Equity Residential、Infinera
Delcath Systems(DCTH.US)获Craig-Hallum首次覆盖,给予买入评级, 目标价18.00美元。
智通财经 · 06-28
Delcath Systems(DCTH.US)获Craig-Hallum首次覆盖,给予买入评级, 目标价18.00美元。
公司概况
公司名称:
迪卡斯
所属市场:
NASDAQ
上市日期:
--
主营业务:
Delcath Systems, Inc.于1988年8月在特拉华州公司注册成立。该公司是一家介入肿瘤学公司,专注于原发性和肝脏转移性癌症的治疗。该公司的主导产品HEPZATOTM KIT(“HEPZATO”melphalan for Injection/ liver Delivery System)是一种药物/设备组合产品,于2023年8月14日获得美国食品和药物管理局(FDA)的批准,用于治疗伴有不可切除肝转移的葡萄膜黑色素瘤成年患者,该患者的肝脏转移影响不到50%的肝脏,无肝外疾病,或肝外疾病局限于骨骼、淋巴结、皮下组织。
发行价格:
--
{"stockData":{"symbol":"DCTH","market":"US","secType":"STK","nameCN":"迪卡斯","latestPrice":11.44,"timestamp":1734987600000,"preClose":11.01,"halted":0,"volume":276703,"hourTrading":{"tag":"盘前","latestPrice":11.52,"preClose":11.44,"latestTime":"07:47 EST","volume":2,"amount":24.310002,"timestamp":1735044476778},"delay":0,"floatShares":25409699,"shares":31973784,"eps":-1.300874,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.43,"latestTime":"12-24 07:49:01 EST","open":11.08,"high":11.51,"low":10.75,"amount":3089750.645821,"amplitude":0.069028,"askPrice":14.11,"askSize":100,"bidPrice":9.19,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.300874,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735050600000},"adr":0,"adjPreClose":11.44,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":11.52,"preClose":11.44,"latestTime":"07:47 EST","volume":2,"amount":24.310002,"timestamp":1735044476778},"postHourTrading":{"tag":"盘后","latestPrice":11.44,"preClose":11.44,"latestTime":"17:53 EST","volume":10,"amount":114.31,"timestamp":1734994402019},"volumeRatio":0.5870101370693636,"impliedVol":0.3335,"impliedVolPercentile":0.1633},"requestUrl":"/m/hq/s/DCTH/wiki","defaultTab":"wiki","newsList":[{"id":"2482462486","title":"德尔卡斯系统公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482462486","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482462486?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:15","pubTimestamp":1731082558,"startTime":"0","endTime":"0","summary":"德尔卡斯系统公司报告截至 9 月 30 日的季度业绩 - 收益摘要Delcath Systems Inc DCTH.OQ公布的截至9月30日的季度调整后每股收益为6美分,高于去年同期的每股收益1.14美元。七位分析师对该季度的平均预期是每股亏损 20 美分。公司报告的季度净收入为 186 万美元。Delcath Systems Inc的股价在本季度上涨了21.2%,今年迄今为止上涨了163.0%。华尔街对 Delcath Systems Inc 的 12 个月目标价中位数为 21.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF1X1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCTH","BK4082"],"gpt_icon":0},{"id":"2481006656","title":"Delcath Systems Inc 预计每股亏损20美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481006656","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481006656?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:22","pubTimestamp":1730902979,"startTime":"0","endTime":"0","summary":"Delcath Systems Inc 预计每股亏损20美分 - 财报前瞻Delcath Systems Inc DCTH.OQ DCTH.O将于11月8日公布截至2024年9月30日的季度财报,预计该公司的季度收入将有所增长。LSEG 分析师对 Delcath Systems Inc 的平均预期是每股亏损 20 美分。华尔街对 Delcath Systems Inc 的 12 个月目标价中位数为 21.50 美元,高于其最后收盘价 10.90 美元。11月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4T3MD2IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCTH"],"gpt_icon":0},{"id":"2477865588","title":"更新版 2-消费者支出放缓,希尔顿下调 2024 年客房收入增长预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2477865588","media":"路透中文","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477865588?lang=zh_cn&edition=full","pubTime":"2024-10-23 18:18","pubTimestamp":1729678733,"startTime":"0","endTime":"0","summary":"更新版 2-消费者支出放缓,希尔顿下调 2024 年客房收入增长预期第2段增加了股票走势,第5、6段增加了细节和首席执行官评论。路透10月23日 - 希尔顿全球HLT.N周三下调了其年度客房收入增长预期的上限,原因是欧洲稳定的旅游需求不足以抵消中国旅游需求的下降和美国旅游需求的放缓。面对宏观经济的困难,中国的消费支出也有所放缓。希尔顿预计 2024 年全系统的客房收入增长率将在 2% 至 2.5% 之间,而之前的增长率范围为 2% 至 3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241023:nL4T3LZ14Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4142","MAR","BK4585","LU1718418525.SGD","BK4588","DCTH","LU0823411888.USD","PK","BK4082","BK4218","HLT","LU0154245673.USD","BK4566","LU0154245756.USD","BK4181","LU0061475181.USD"],"gpt_icon":0},{"id":"2476020651","title":"BUZZ-德尔卡斯系统公司第三季度营收预期高于预期,公司业绩上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2476020651","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476020651?lang=zh_cn&edition=full","pubTime":"2024-10-18 00:50","pubTimestamp":1729183821,"startTime":"0","endTime":"0","summary":"** 根据LSEG汇编的数据,该公司预计 ,第三季度营收为1120万美元,高于分析师平均预期的945万美元。** 该公司称其第三季度在美国的收入为1000万美元,来自于Hepzato Kit的商业化,这是一种治疗癌症的药物和设备组合产品。** DCTH表示, 1,000万美元的美国季度收入里程碑触发了2,500万美元的融资,该公司将利用这笔资金支持正在进行的商业化启动,并投资于新的试验,以扩大其计划于2025年启动的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCTH"],"gpt_icon":0},{"id":"1154934630","title":"这9只生物科技股今年已暴涨翻倍,分析师预测未来还有翻倍空间!","url":"https://stock-news.laohu8.com/highlight/detail?id=1154934630","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154934630?lang=zh_cn&edition=full","pubTime":"2024-10-17 13:46","pubTimestamp":1729143997,"startTime":"0","endTime":"0","summary":"9只医疗保健股票今年股价已经翻倍,根据分析师的预测,这9只股票未来仍有超过100%的上涨潜力。生物科技行业的股票通常被分析师视为比其他行业的投资风险更高。根据五位分析师的目标价中值,预计 Benitec 未来 12 个月将上涨 104%。Praxis今年迄今已上涨223%,跟踪该股票的10位分析师预计未来12个月将上涨103%。Humacyte今年已翻倍,分析师预计它在未来12个月内还将再次翻倍。","market":"us","thumbnail":"https://community-static.tradeup.com/news/ae91103f9636ad1491772cb329b87218","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/ae91103f9636ad1491772cb329b87218"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"这9只生物科技股今年已暴涨翻倍,分析师预测未来还有翻倍空间!","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRAX","DCTH","ARQT","JSPR","CRBP","TRVI","HUMA","RZLT","BNTC"],"gpt_icon":1},{"id":"2457089164","title":"德尔卡斯系统公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457089164","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457089164?lang=zh_cn&edition=full","pubTime":"2024-08-06 05:30","pubTimestamp":1722893438,"startTime":"0","endTime":"0","summary":" * Delcath Systems Inc 报告,截至6月底的季度调整后每股亏损48美分,高于去年同期的每股-67美分。七位分析师对该季度的平均预期是每股亏损 36 美分。华尔街预期为每股-42美分至-24美分。* 营收同比增长 1468.9%,达到 777 万美元;分析师预期为 523 万美元。* Delcath Systems Inc公布的本季度每股收益为亏损48美分。* 该公司当季亏损1389万美元。* Delcath Systems Inc本季度股价下跌了3.0%,今年迄今为止上涨了95.2%。华尔街对 Delcath Systems Inc 的 12 个月目标价中位数为 21.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德尔卡斯系统公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","DCTH"],"gpt_icon":0},{"id":"2457724539","title":"迪卡斯系统:核准有效期为从10月1日开始的财政年度。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457724539","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457724539?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:34","pubTimestamp":1722861295,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4082","DCTH"],"gpt_icon":0},{"id":"2457533724","title":"迪卡斯:康哲药业获得Hepzato套件的CMS Ntap状态。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457533724","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457533724?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:34","pubTimestamp":1722861281,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4208","SG9999015952.SGD","00867","LU2637428348.USD","CMS","SG9999015978.USD","BK4585","LU2488822045.USD","DCTH","BK1191","BK4588","SG9999004220.SGD","BK4082","BK1593","SG9999015986.USD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2456285952","title":"Delcath Systems Inc 预计每股亏损36美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456285952","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456285952?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:02","pubTimestamp":1722603755,"startTime":"0","endTime":"0","summary":" * Delcath Systems Inc 将于8月5日发布截至2024年6月30日的季度财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,6位分析师的平均预期显示,这家总部位于纽约Queensbury的公司的营收预计将从去年同期的49.5万美元增至522.7万美元,增幅为955.9%。* LSEG 分析师对 Delcath Systems Inc 的平均预期是每股亏损 36 美分。* 华尔街对 Delcath Systems Inc 的 12 个月目标价中位数为 21.00 美元,高于其最新收盘价 8.19 美元。8月2日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Delcath Systems Inc 预计每股亏损36美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCTH"],"gpt_icon":0},{"id":"2446582501","title":"美国研究综述-Alphabet、Equity Residential、Infinera","url":"https://stock-news.laohu8.com/highlight/detail?id=2446582501","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446582501?lang=zh_cn&edition=full","pubTime":"2024-06-28 20:16","pubTimestamp":1719577011,"startTime":"0","endTime":"0","summary":" 路透6月28日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,其中包括 Alphabet、Equity Residential 和 Infinera。要闻 * Alphabet Inc :罗森布拉特证券公司将其评级从 \"买入 \"下调至 \"中性\"。* Cincinnati Financial Corp :花旗集团将其评级从 \"买入 \"上调至 \"买入 * Equity Residential :Piper Sandler将其评级从中性上调至增持 * 英飞朗 :Stifel将其评级从 \"买入 \"下调至 \"持有 以下是路透周五报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQH","AMP","BL","DAY","ALSN","LU0128525929.USD","AFL","CERT","AFG","LU0708995401.HKD","DAL","DLTR","AOSL","BKR","CALC","DE","GOOGL","LU0106831901.USD","AR","CMG","IE00BJTD4N35.SGD","CHK","LU0494093205.USD","APOG","TXG","LU0061475181.USD","LU0109391861.USD","CRL","AGCO","CHPT","CINF","BWIN","LU2264538146.SGD","DCTH","BB","T","AVTR","DLR","LU1280957306.USD","ELAN","CRBG","BHF","BP","ACCD","ARRY","CRK","CHWY","CTLT"],"gpt_icon":0},{"id":"2446505909","title":"Delcath Systems(DCTH.US)获Craig-Hallum首次覆盖,给予买入评级, 目标价18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446505909","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446505909?lang=zh_cn&edition=full","pubTime":"2024-06-28 19:35","pubTimestamp":1719574527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["DCTH","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.delcath.com","stockEarnings":[{"period":"1week","weight":-0.0638},{"period":"1month","weight":0.1721},{"period":"3month","weight":0.2796},{"period":"6month","weight":0.4123},{"period":"1year","weight":1.8529},{"period":"ytd","weight":1.75}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0012},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.2557},{"period":"ytd","weight":0.2514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Delcath Systems, Inc.于1988年8月在特拉华州公司注册成立。该公司是一家介入肿瘤学公司,专注于原发性和肝脏转移性癌症的治疗。该公司的主导产品HEPZATOTM KIT(“HEPZATO”melphalan for Injection/ liver Delivery System)是一种药物/设备组合产品,于2023年8月14日获得美国食品和药物管理局(FDA)的批准,用于治疗伴有不可切除肝转移的葡萄膜黑色素瘤成年患者,该患者的肝脏转移影响不到50%的肝脏,无肝外疾病,或肝外疾病局限于骨骼、淋巴结、皮下组织。","yearOnYearQuotes":[{"month":1,"riseRate":0.565217,"avgChangeRate":0.015128},{"month":2,"riseRate":0.391304,"avgChangeRate":-0.069788},{"month":3,"riseRate":0.434783,"avgChangeRate":-0.036447},{"month":4,"riseRate":0.347826,"avgChangeRate":0.247905},{"month":5,"riseRate":0.391304,"avgChangeRate":-0.063861},{"month":6,"riseRate":0.391304,"avgChangeRate":3.67248},{"month":7,"riseRate":0.434783,"avgChangeRate":-0.076767},{"month":8,"riseRate":0.521739,"avgChangeRate":0.016759},{"month":9,"riseRate":0.304348,"avgChangeRate":-0.071209},{"month":10,"riseRate":0.347826,"avgChangeRate":-0.06516},{"month":11,"riseRate":0.291667,"avgChangeRate":-0.086466},{"month":12,"riseRate":0.541667,"avgChangeRate":0.059616}],"exchange":"NASDAQ","name":"迪卡斯","nameEN":"DELCATH SYSTEMS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迪卡斯(DCTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迪卡斯(DCTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迪卡斯,DCTH,迪卡斯股票,迪卡斯股票老虎,迪卡斯股票老虎国际,迪卡斯行情,迪卡斯股票行情,迪卡斯股价,迪卡斯股市,迪卡斯股票价格,迪卡斯股票交易,迪卡斯股票购买,迪卡斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迪卡斯(DCTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迪卡斯(DCTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}